ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline Aims To Improve Hormone Receptor Testing

April 23, 2010

In Brief: NIH Peer Review Reorganization Proposed By Advisory Panel; Comments Sought

September 3, 1999

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program”

June 3, 1988

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981